This map shows the geographic impact of JS Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JS Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JS Whelan more than expected).
This network shows the impact of papers produced by JS Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JS Whelan. The network helps show where JS Whelan may publish in the future.
Co-authorship network of co-authors of JS Whelan
This figure shows the co-authorship network connecting the top 25 collaborators of JS Whelan.
A scholar is included among the top collaborators of JS Whelan based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with JS Whelan. JS Whelan is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bielack, Stefan, Beate Kempf‐Bielack, Thekla von Kalle, et al.. (2013). Controversies in childhood osteosarcoma.. PubMed. 65(2). 125–48.21 indexed citations
3.
Whelan, JS, Paolo G. Casali, & Jean‐Yves Blay. (2010). Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO/CONTICANET/EUROBONET Consensus Panel of Experts.. UCL Discovery (University College London).72 indexed citations
4.
McTiernan, Anne, Gareth Morgan, Barbara Uscinska, et al.. (2008). The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup.. UCL Discovery (University College London).1 indexed citations
5.
Whelan, JS, et al.. (2006). Current Management of Osteosarcoma.. UCL Discovery (University College London).
6.
Daw, Stephen, et al.. (2005). High-dose ifosfamide in relapsed or progressive Ewing's sarcoma.. UCL Discovery (University College London).2 indexed citations
Møller, Henrik, et al.. (2003). The incidence of cancer in adolescents and young adults in South East England. An analysis of Thames Cancer Registry Data 1998-2000. UCL Discovery (University College London). 88.9 indexed citations
Spanswick, Victoria J., et al.. (1999). Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay.. PubMed. 5(3). 507–12.80 indexed citations
Radford, John, et al.. (1990). VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres.. UCL Discovery (University College London).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.